The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models
Rezafungin is a novel echinocandin in Phase 3 development for prevention of invasive fungal disease caused by <i>Candida</i> spp., <i>Aspergillus</i> spp. and <i>Pneumocystis jirovecii</i> in blood and marrow transplantation patients. For such patients, standard a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-09-01
|
| Series: | Journal of Fungi |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2309-608X/7/9/747 |